glp-1 triple agonist Calling retatrutide a “GLP-3” is usually a quick sign that you don't understand the underlying biology. Retatrutide is a NuSH-based agonist—it targets GLP-1, GIP, and Glucagon receptors. Only one of those LY3437943, a novel triple glucagon,
Pay in 4 interest-free payments of $6.07 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5


























